Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5927)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2022 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee KN, Lee OY, Chun HJ, Kim JI, Kim SK, Lee SW, Park KS, Lee KL, Choi SC, Jang JY, Kim GH, Sung IK, Park MI, Kwon JG, Kim N, Kim JJ, Lee ST, Kim HS, Kim KB, Lee YC, Choi MG, Lee JS, Jung HY, Lee KJ, Kim JH, Chung H. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J Gastroenterol 2022; 28(44): 6294-6309 [PMID: 36504556 DOI: 10.3748/wjg.v28.i44.6294] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i44/6294.htm |
| Number | Citing Articles |
| 1 |
Byeong Yun Ahn, Soo-Jeong Cho. Potassium-competitive Acid Blockers: A New Therapeutic Strategy for Helicobacter pylori Eradication. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(3): 174 doi: 10.7704/kjhugr.2023.0041
|
| 2 |
Jiten P. Kothadia, Colin W. Howden. Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease. Foregut: The Journal of the American Foregut Society 2024; 4(1): 7 doi: 10.1177/26345161231181357
|
| 3 |
Yuan Fang, Xia He, Ai Peng, Yi qi Yang, Jin Xiang. Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms. Clinical Pharmacology in Drug Development 2024; 13(2): 134 doi: 10.1002/cpdd.1334
|
| 4 |
Inyoung Hwang, SeungHwan Lee. Editorial: deja vu all over again – let the P‐CAB wars begin. Authors' reply. Alimentary Pharmacology & Therapeutics 2023; 57(8): 914 doi: 10.1111/apt.17444
|
| 5 |
Jong Kyu Park. Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(3): 180 doi: 10.7704/kjhugr.2023.0034
|
| 6 |
Wonsuk Shin, A-Young Yang, Hyung Park, Hyejung Lee, Hyounggyoon Yoo, Anhye Kim. A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State. Pharmaceuticals 2023; 16(8): 1141 doi: 10.3390/ph16081141
|
| 7 |
Ah Young Yoo, Moon Kyung Joo, Jong-Jae Park, Beom Jae Lee, Seung Han Kim, Won Shik Kim, Hoon Jai Chun. Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy. Diagnostics 2023; 13(22): 3444 doi: 10.3390/diagnostics13223444
|
| 8 |
Erika Araujo, Ian M. Bell, Alexander Burckle, Dennis C. Koester, James R. Manning, Georgette Castanedo, Mingshuo Zeng, T. G. Murali Dhar, Natalie Holmberg-Douglas, Eric R. Welin, J. Robert Merritt, Kevin M. Peese, Joanne J. Bronson. 2023 Medicinal Chemistry Reviews. Medicinal Chemistry Reviews 2023; 58: 595 doi: 10.1021/mc-2023-vol58.ch24
|
| 9 |
Qianjun Zhuang, Aijun Liao, Qingling He, Chengxia Liu, Changqing Zheng, Xing Li, Youli Liu, Bangmao Wang, Side Liu, Yan Zhang, Rong Lin, Huixin Chen, Min Deng, Yanping Tang, Chiyi He, Weijie Dai, Haitao Tang, Lei Gong, Liangping Li, Baohong Xu, Changqing Yang, Bingxi Zhou, Dongxing Su, Qinghong Guo, Bin Li, Yongjian Zhou, Xiaoyang Wang, Sujuan Fei, Huili Wu, Sichen Wei, Zhihong Peng, Jianning Wang, Yanqing Li, Hong Wang, Tianwei Deng, Shigang Ding, Fangfang Li, Minhu Chen, Yinglian Xiao. The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study. Journal of Gastroenterology and Hepatology 2024; 39(4): 658 doi: 10.1111/jgh.16471
|
| 10 |
Dong Han Yeom, Yong Sung Kim. History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(3): 159 doi: 10.7704/kjhugr.2023.0040
|
| 11 |
E. A. Ortenberg, M. V. Lyapina, E. F. Dorodnyeva. Competitive proton pump inhibitors - status and Prospects of use. Experimental and Clinical Gastroenterology 2023; (4): 86 doi: 10.31146/1682-8658-ecg-212-4-86-92
|
| 12 |
Mun Young Cho, Yu Kyung Cho. Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(3): 167 doi: 10.7704/kjhugr.2023.0043
|
| 13 |
Azaan Ramani, Alisha Merchant, Brooks D. Cash. Review of the clinical development of fexuprazan for gastroesophageal reflux–related disease. European Journal of Clinical Pharmacology 2023; 79(8): 1023 doi: 10.1007/s00228-023-03521-4
|